ArticleCancers2020

Prospective Assessment of Systemic MicroRNAs as Markers of Response to Neoadjuvant Chemotherapy in Breast Cancer.

Andrew McGuire et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.